A Phase I/IIa Randomized Double-Blind Dose-Ranging Placebo-Controlled Study of the Safety and Immunogenicity of a HSV-2 Vaccine Containing Matrix M-2 Adjuvant in Individuals with Documented Genital HSV-2 Genital Infection
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The primary purpose of this research study is to see if a new investigational vaccine, GEN-003, is safe in individuals with genital HSV-2.
Description
The primary purpose of this research study is to see if a new investigational vaccine, GEN-003, is safe in individuals with genital HSV-2.
Details
| Condition | Genital Herpes |
|---|---|
| Age | 18years - 50years |
| Clinical Study Identifier | TX2392 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.